Author Question: The nurse is concerned that a patient with HIV who has been taking the protease inhibitor ritonavir ... (Read 58 times)

jilianpiloj

  • Hero Member
  • *****
  • Posts: 521
The nurse is concerned that a patient with HIV who has been taking the protease inhibitor ritonavir (Norvir) is developing lipodystrophy. What did the nurse assess to come to this conclusion? (Select all that apply.)
 
  1. Skin rash
  2. Thin arms
  3. Sunken cheeks
  4. Emaciated legs
  5. Enlarged abdomen

Question 2

The nurse is preparing a community teaching program aimed at prevention of human immunodeficiency virus (HIV) transmission. The nurse is aware that the population at high risk for becoming infected with HIV includes:
 
  1. young African-American males.
  2. young Puerto Rican females.
  3. older Asian and African-American males.
  4. white females from 16 to 26 years of age.



robbielu01

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

Answer: 2, 3, 4, 5

1. A skin rash is not a manifestation of lipodystrophy.
2. Most protease inhibitors cause lipodystrophy, which causes a loss of tissue in the arms.
3. Most protease inhibitors cause lipodystrophy, which causes a loss of tissue from the face.
4. Most protease inhibitors cause lipodystrophy, which causes a loss of tissue from the legs.
5. Most protease inhibitors cause lipodystrophy, which causes an enlarged abdomen.

Answer to Question 2

Answer: 1

1. AIDS is the leading cause of death among African American males ages 25 to 44.
2. AIDS is the leading cause of death among African American males ages 25 to 44.
3. AIDS is the leading cause of death among African American males ages 25 to 44.
4. AIDS is the leading cause of death among African American males ages 25 to 44.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.

Did you know?

Malaria mortality rates are falling. Increased malaria prevention and control measures have greatly improved these rates. Since 2000, malaria mortality rates have fallen globally by 60% among all age groups, and by 65% among children under age 5.

For a complete list of videos, visit our video library